| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2002 | EP1144408B1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application |
| 09/25/2002 | EP1100456B1 Use of ectoine or ectoine derivatives in formulations |
| 09/25/2002 | EP1089763B1 Agents for specifically inhibiting osteoclastic bone resorption |
| 09/25/2002 | EP1089761B1 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
| 09/25/2002 | EP1073651B1 Indolyl derivatives as serotonergic agents |
| 09/25/2002 | EP1070059B1 Chromanone and thiochromanone derivatives |
| 09/25/2002 | EP1069884B1 Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids |
| 09/25/2002 | EP1067905B1 Fizzy formulations |
| 09/25/2002 | EP1064293B1 Crystallization of lactitol, crystalline lactitol product and use thereof |
| 09/25/2002 | EP1030668A4 Penetration enhancing and irritation reducing systems |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP1003528B1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 09/25/2002 | EP1001951B1 Thiazole derivatives, method for their production and use |
| 09/25/2002 | EP0994710B1 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin |
| 09/25/2002 | EP0986390B1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 09/25/2002 | EP0981549B1 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 09/25/2002 | EP0980263B1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 09/25/2002 | EP0977559B1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0938306B1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives |
| 09/25/2002 | EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 09/25/2002 | EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/25/2002 | EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 09/25/2002 | EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/25/2002 | EP0918521B1 Formulation for the treatment and/or prophylaxis of dementia |
| 09/25/2002 | EP0915870B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 09/25/2002 | EP0912613B1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 09/25/2002 | EP0912534B1 Muscarinic antagonists |
| 09/25/2002 | EP0912184B1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/25/2002 | EP0912176B1 Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression |
| 09/25/2002 | EP0910398B1 Method of stimulating cilia |
| 09/25/2002 | EP0907635B1 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 09/25/2002 | EP0904087B1 Phosphatidic acid-comprising compositions |
| 09/25/2002 | EP0845981B1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 09/25/2002 | EP0841928B1 Sustained-release formulation of d-threo-methylphenidate |
| 09/25/2002 | EP0841912B1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 09/25/2002 | EP0817782B1 Phenyl derivatives useful as endothelin receptor antagonists |
| 09/25/2002 | EP0806958A4 Inhibition of platelet binding |
| 09/25/2002 | EP0753297B1 Lotion |
| 09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 09/25/2002 | EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor |
| 09/25/2002 | EP0746325B1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | EP0686147B1 Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity |
| 09/25/2002 | EP0641795B1 Carbapenem derivative |
| 09/25/2002 | CN1371391A Heparin compositions that inhibit clot associated coagulation factors |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371386A Spherical telithromycikn clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 09/25/2002 | CN1371385A Immunopotentiating compositions |
| 09/25/2002 | CN1371381A Improved amorphous form of cefpodoxime proxetil |
| 09/25/2002 | CN1371379A New indolocarbazole alkaloids from marine actinomycete |
| 09/25/2002 | CN1371376A Substituted purin derivatives as inhibitors of cell adhesion |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/25/2002 | CN1371372A Novel chalcones |
| 09/25/2002 | CN1371371A Novel derivatives of flavones, xanthones and coumarins |
| 09/25/2002 | CN1371370A Chalcone coumarins |
| 09/25/2002 | CN1371369A Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and their use das lipase inhibitors |
| 09/25/2002 | CN1371367A Phenethyl-5-bromopyridyl thiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 09/25/2002 | CN1371366A Benzamide formulation with histone deacetylase inhibitor activity |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371291A Method and formula for tumor remission and suppression of cancer |
| 09/25/2002 | CN1371288A Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371282A Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 09/25/2002 | CN1371281A Soft capsules |
| 09/25/2002 | CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 09/25/2002 | CN1371279A Metabolites of ecteinascidin 743 |
| 09/25/2002 | CN1371278A Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 09/25/2002 | CN1371277A Pharmaceutical tramadol salts |
| 09/25/2002 | CN1371275A Arificial tear replacement solution |
| 09/25/2002 | CN1371274A 化妆品组合物 Cosmetic composition |
| 09/25/2002 | CN1371273A Cosmetic composition containing quaternary ammonium compound and tocopherol |
| 09/25/2002 | CN1371272A Cosmetic composition containing pantothenic acid |
| 09/25/2002 | CN1371271A 化妆品组合物 Cosmetic composition |
| 09/25/2002 | CN1371270A Cosmetic method |
| 09/25/2002 | CN1371267A 化妆品组合物 Cosmetic composition |
| 09/25/2002 | CN1370577A Kangfushuang cream for treating allergic dermatitis, eczama and other skin inflammations |
| 09/25/2002 | CN1370570A Medicine compoistion for traeting burns and scalds |
| 09/25/2002 | CN1370557A Ulcer treating capsule and its prepn |
| 09/25/2002 | CN1370539A Prepn of isolator for preventing post-operation adhesion of abdominal cavity |
| 09/25/2002 | CN1370538A Medicinal composite containing staphdine and dideoxyinosine |
| 09/25/2002 | CN1370537A New medicinal use and prepn process of steroid general saponin of Rhizoma Anemarrhenae as Chinese medicine |
| 09/25/2002 | CN1370536A Exogenous medicinal animal active gene liquid and its extraction method and application |
| 09/25/2002 | CN1370535A Method of inhibiting skin damage of vitamin A analog |
| 09/25/2002 | CN1370534A Medicine for treating polycystic kidney disease |
| 09/25/2002 | CN1370533A Application of new benzothiophene compound in preventing and treating women's post-menopause syndrome and other estrogen relative diseases |
| 09/25/2002 | CN1370532A Maleic amlodipine besylate tablet as cardiovascular disease treating medicine and its prepn |
| 09/25/2002 | CN1370531A Combined therapy |
| 09/25/2002 | CN1370530A Anticancer lichee lectone medicine and its prepn |
| 09/25/2002 | CN1370529A Medicine for treating spinal cord lesion |
| 09/25/2002 | CN1370528A Medicine for treating insomnia and mental disturbance |
| 09/25/2002 | CN1370527A Toxoprotein, medicament for toxoprotein caused disease and the disease preventing and treating method |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |